WebMD Global requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships with ineligible companies.

Faculty

Per Henrik Groop, MD

Professor of Internal Medicine
Chief Physician
Department of Nephrology
University of Helsinki
Helsinki University Hospital
Principal Investigator
Folkhälsan Research Center
Helsinki, Finland

Disclosures

Consultant or advisor for: Astellas; AstraZeneca; Bayer; Boehringer Ingelheim; Eli Lilly; Merck Sharp & Dohme; Mundipharma; Novartis; Novo Nordisk; Sanofi
Speaker or member of speakers bureau for: Astellas; AstraZeneca; Bayer; Boehringer Ingelheim; Eli Lilly; Merck Sharp & Dohme; Mundipharma; Novartis; Novo Nordisk; PeerVoice; Sanofi
Research funding from: Eli Lilly; F. Hoffmann-La Roche

Editors

Rita Moreira Da Silva, PharmD, MA, PhD

Medical Education Director, WebMD Global, LLC

Disclosures

Disclosure: Rita Moreira Da Silva, PharmD, MA, PhD, has no relevant financial relationships.

Gina Montanero, PharmD

Associate Medical Writer, Medscape, LLC 

Disclosures

Disclosure: Gina Montanero, PharmD, has no relevant financial relationships.

Compliance Reviewer

Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP

Associate Director, Accreditation and Compliance

Disclosures

Disclosure: Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

CPD

Focus on the Diabetes Patient at Risk of Chronic Kidney Disease in Clinical Practice

Authors: Per Henrik Groop, MD
CPD Released: 5/25/2022
THIS ACTIVITY HAS EXPIRED FOR CREDIT
Valid for credit through: 5/25/2023, 11:59 PM EST

Start Activity

Target Audience and Goal Statement

This educational activity is intended for an international audience of non-US primary care physicians, diabetologists/endocrinologists, nephrologists, and cardiologists.

The goal of this activity is to improve physicians’ competence in managing patients with diabetes at risk of or with cardiorenal disease in clinical practice.

Upon completion of this activity, participants will:

Have increased knowledge regarding the
- Need for comprehensive control of vascular risk control in patients with type 2 diabetes (T2D)
Have greater competence related to
- The practical implementation of the latest diabetes guidelines for the individualized management of patients with T2D with chronic kidney disease

Disclosures

Faculty

Per Henrik Groop, MD

Professor of Internal Medicine
Chief Physician
Department of Nephrology
University of Helsinki
Helsinki University Hospital
Principal Investigator
Folkhälsan Research Center
Helsinki, Finland

Disclosures

Consultant or advisor for: Astellas; AstraZeneca; Bayer; Boehringer Ingelheim; Eli Lilly; Merck Sharp & Dohme; Mundipharma; Novartis; Novo Nordisk; Sanofi
Speaker or member of speakers bureau for: Astellas; AstraZeneca; Bayer; Boehringer Ingelheim; Eli Lilly; Merck Sharp & Dohme; Mundipharma; Novartis; Novo Nordisk; PeerVoice; Sanofi
Research funding from: Eli Lilly; F. Hoffmann-La Roche

Editors

Rita Moreira Da Silva, PharmD, MA, PhD

Medical Education Director, WebMD Global, LLC

Disclosures

Disclosure: Rita Moreira Da Silva, PharmD, MA, PhD, has no relevant financial relationships.

Gina Montanero, PharmD

Associate Medical Writer, Medscape, LLC 

Disclosures

Disclosure: Gina Montanero, PharmD, has no relevant financial relationships.

Compliance Reviewer

Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP

Associate Director, Accreditation and Compliance

Disclosures

Disclosure: Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

Accreditation Statements

For Physicians

The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it 0.25 continuing professional development credits (CPD).

Contact WebMD Global

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information about your eligibility to claim credit, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent participating in the activity. To successfully earn credit, participants must complete the activity online during the credit eligibility period that is noted on the title page.

Follow these steps to claim a credit certificate for completing this activity:

Read the information provided on the title page regarding the target audience, learning objectives, and author disclosures, read and study the activity content and then complete the post-test questions. If you earn a passing score on the post-test and we have determined based on your registration profile that you may be eligible to claim CPD credit for completing this activity, we will issue you a CPD credit certificate.
Once your CPD credit certificate has been issued, you may view and print the certificate from your CME/CE Tracker. CPD credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of the Medscape Education homepage.

We encourage you to complete an Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

From Medscape Education

CPD

Focus on the Diabetes Patient at Risk of Chronic Kidney Disease in Clinical Practice

Authors: Per Henrik Groop, MDFaculty and Disclosures

THIS ACTIVITY HAS EXPIRED FOR CREDIT

CPD Released: 5/25/2022

Valid for credit through: 5/25/2023, 11:59 PM EST

processing....

Subtítulos en español

« Return to: Focus on the Diabetes Patient at Risk of Chronic Kidney Disease in Clinical Practice

Download Slides

Activity Transcript

Print
Like Tweet

Faculty and Disclosures

Faculty

Per Henrik Groop, MD

Editors

Rita Moreira Da Silva, PharmD, MA, PhD

Gina Montanero, PharmD

Compliance Reviewer

Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP

Peer Reviewer

CPD

Focus on the Diabetes Patient at Risk of Chronic Kidney Disease in Clinical Practice

Target Audience and Goal Statement

Disclosures

Faculty

Per Henrik Groop, MD

Editors

Rita Moreira Da Silva, PharmD, MA, PhD

Gina Montanero, PharmD

Compliance Reviewer

Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP

Peer Reviewer

Accreditation Statements

For Physicians

Instructions for Participation and Credit

Focus on the Diabetes Patient at Risk of Chronic Kidney Disease in Clinical Practice

Subtítulos en español